In this study, ADAM17 knockdown reduced the shedding of ACE2, thereby increasing ACE2 expression in a high-glucose environment, which had an antagonistic effect on Ang II and improved cardiac function in DCM. The gene discussed is AGT; the disease is familial dilated cardiomyopathy.